Probe speeds detection of deep lung infections in patients

February 15, 2018, University of Edinburgh

A medical imaging technology under development has enabled doctors to see bacteria deep inside patients' lungs for the first time.

Early tests indicate the bedside may be able to detect in ' lungs in less than 60 seconds.

Fast diagnosis would enable to be given the right medicine quickly and could avoid unnecessary use of antibiotics.

The technology is being showcased at the Annual Congress of the American Association for the Advancement of Science in Austin, Texas, on 15-19 February.

Each year around 20 million patients in need ventilators to help them breathe. Up to one-third of these patients are suspected to have serious lung infections.

Doctors currently diagnose infections using X-rays, which are imprecise. Tests on fluid samples extracted from patients' lungs may also be used, but these can take days to return a result.

Researchers from the Universities of Edinburgh and Bath and Heriot-Watt University are developing a new approach with major funding from the UK's Engineering and Physical Sciences Research Council (EPSRC).

The consortium - called Proteus - is developing the imaging tool that can reach deeper into the lungs than existing devices.

The team have designed that can be sprayed into patients lungs, which light up when they attach to specific types of infectious bacteria.

This fluorescence is detected using fibre-optic tubes that are small enough to travel deep inside patients' lungs.

The team is currently testing the chemical probes in clinical trials involving patients with a chronic condition called bronchiectasis.

Tests are also under way with who are being ventilated and are suspected of having pneumonia.

If the approach proves successful, doctors expect it will greatly speed up their ability to provide life-saving treatments for patients in intensive care.

At the moment, critically ill patients who are suspected to have an infection are often treated with powerful antibiotics as a precaution, before any infection is confirmed. These medicines can have side effects and are expensive.

This blanket approach to therapy can also contribute to the emergence of bacteria that are resistant to antibiotics, experts say.

The Proteus system aims to cut the use of antibiotics by pinpointing patients who will benefit and those who will not.

In addition to the chemical probes, the researchers are developing bespoke optical fibres and new detector technologies that will allow sensing as well as imaging deep inside the lung. This will enable doctors to measure biological changes in the , such as oxygen levels and acidity.

In parallel, the team are adapting the technology to detect and treat other types of infection and illness - such as fungi and cancer

Proteus has also received funding from the Medical Research Council, Wellcome and CARB-X, the world's largest public-private partnership devoted to antibacterial early development research.

Kev Dhaliwal, Professor of Molecular Imaging & Healthcare Technology at the University of Edinburgh, said: "Our team is making rapid progress in bringing together many technologies to help us develop entirely new approaches to diagnose and treat disease at the bedside.

Professor Philip Nelson, Chief Executive of the UK's Engineering and Physical Sciences Research Council (EPSRC) said, "The strength of the Proteus team is that it links the expertise and knowledge of people skilled in engineering, science and medicine. By investing in this research the research councils and their partners are making a real impact on the lives of patients both in the UK and elsewhere in the world. Collaboration is the key here and we look forward to seeing the techniques developed reaching the wider marketplace."

Explore further: Lung probe that spots infections aims to cut antibiotic overuse

Related Stories

Lung probe that spots infections aims to cut antibiotic overuse

March 30, 2017
A new imaging tool that rapidly diagnoses bacterial lung infections could help prevent unnecessary use of antibiotics in intensive care units.

Novel PET tracer clearly identifies and tracks bacterial infection in lungs

January 8, 2018
Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2-18F-fluorodeoxysorbitol (18F-FDS), can identify and track bacterial infection in lungs better than current imaging methods ...

How the microbiome could tackle antibiotic resistant infections in the lungs

August 10, 2017
Understanding how microbes contribute to respiratory health and immunity could help tackle drug resistant infections in the lungs, say scientists.

Glucose in the airways could increase infections in lung disease patients

January 5, 2018
People with the lung disease COPD have higher levels of glucose in their airways, researchers have shown for the first time.

Damaging immune response may be cause of COPD infections

May 25, 2017
Researchers at the University of Dundee have made an important discovery about why patients with chronic obstructive pulmonary disease (COPD) suffer frequent chest infections, potentially paving the way for new treatments.

Four simple tests could help GPs spot pneumonia and reduce unnecessary antibiotics

November 23, 2017
Testing for fever, high pulse rate, crackly breath sounds, and low oxygen levels could be key to helping GPs distinguish pneumonia from less serious infections, according to a large study published in the European Respiratory ...

Recommended for you

A versatile vaccine that can protect mice from emerging tick-borne viruses

December 18, 2018
A group of researchers led by Michael Diamond of Washington University School of Medicine in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause ...

How cholera bacteria make people so sick

December 18, 2018
The enormous adaptability of the cholera bacterium explains why it is able to claim so many victims. Professor Ariane Briegel from the Leiden Institute of Biology has now discovered that this adaptability is due to rapid ...

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.